Clinical Trials Browser

Triple Negative Breast Neoplasms × poly ICLC × Clear all

NCT07300475 2026-02-13

Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients

Phase 1 Not yet recruiting

Triple Negative Breast Neoplasms

NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms